Australia's Leading Ophthalmic Magazine Since 1975

     Free Sign Up     

Australia's Leading Ophthalmic Magazine Since 1975

     Free Sign Up     
News, Business

Zeiss announces record-breaking annual revenue

08/01/2019By Richard Chiu • Staff Journalist
Strong returns in the American and Asia Pacific regions have been key drivers behind a 7.6% annual revenue increase for Carl Zeiss Meditec.

The German medical technology manufacturer reported increased revenue for all strategic business units and regions in the 2017/18 financial year, reaching €1.28 billion (AU$2.02 b), up from €1.19 billion (AU$1.88 b) the year prior. The performance of the medical division bolstered the entire Zeiss Group’s results, contributing to the company’s overall record-breaking revenue and earnings for the 2017/18 financial year.

In the Americas, Carl Zeiss Meditec’s revenue rose 7.5% to €406.5 million (AU$642.3 m), largely due to continued gains in the US market. In the Asia Pacific region, the Chinese and South Korean markets were the main contributors behind a 10.7% revenue increase to €496.3 million (AU$784.2 m).

“We achieved our sales forecast, which we had already raised in July 2018 – in spite of negative currency effects,” president and CEO of Carl Zeiss Meditec Dr Ludwin Monz said.

“In fiscal year 2017/18 we gained further market shares in both ophthalmology and microsurgery. What is particularly encouraging is that all regions and business segments contributed.”

Earnings before interest and taxes (EBIT) rose to €197.1 million (AU$311.4 m), versus €180.8 million (AU$171.8 m) the previous year. The EBIT margin remained stable at 15.4%.

The company’s strategic business unit Ophthalmic Devices increased its revenue by 6% to €933.3 million (AU$1.47 b), while its laser systems business for vision correction and the diagnostics unit progressed significantly. Zeiss also noted continued solid demand for premium and standard intraocular lenses for the treatment of cataracts.

Meanwhile, revenue in the Europe/Middle East/Africa region increased by 4% to €378.1 million (AU$597.4 m). Development in the core German and French markets was stable, while the British, Southern Europe and some Eastern European markets also recorded positive growth.

Alongside the announcement of its results, Carl Zeiss Meditec launched a new astigmatism management system designed for a more precise toric workflow. The Zeiss IOLMaster 700 with Total Keratometry is said to produce precise biometry measurements, while the Zeiss Callisto eye Markerless toric IOL alignment features improved alignment precision compared when compared to manual marking.

AFT Pharmaceuticals

Skyscraper article
Editor's Suggestion
Hot Stories



Subscribe for Insight in your Inbox

Get Insight with the latest in industry news, trends, new products, services and equipment!